We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies

    Natural killer (NK) cell belongs to innate lymphoid cell family that contributes to host immunosurveillance and defense without pre-immunization....

    Juanjuan Shang, Shunfeng Hu, **n Wang in Experimental Hematology & Oncology
    Article Open access 23 February 2024
  2. Infectious mononucleosis complicated by transitory Epstein-Barr virus infection of T and natural killer cells

    Epstein-Barr virus (EBV) typically infects B cells in infectious mononucleosis (IM), but a rare case shows EBV infection in T cells. Seven cases of...

    Yanlin Zhang, JianLan **e, ... **aoGe Zhou in Journal of Hematopathology
    Article Open access 05 July 2024
  3. Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT)

    Gastric cancer is the 5 th most common malignancy worldwide with only 36% of patients with metastatic disease surviving beyond 5 years. Despite...

    Matthew J. Hadfield, Howard Safran, ... Benedito A. Carneiro in Oncogene
    Article 29 January 2024
  4. Chimeric antigen receptor engineered natural killer cells for cancer therapy

    Natural killer (NK) cells, a unique component of the innate immune system, are inherent killers of stressed and transformed cells. Based on their...

    Yalan Zhang, Weilin Zhou, ... Wei Wang in Experimental Hematology & Oncology
    Article Open access 10 August 2023
  5. Natural killer cells strengthen antitumor activity of cisplatin by immunomodulation and ameliorate cisplatin-induced side effects

    Purpose

    Cisplatin-based chemotherapy is now an important treatment for improving bladder cancer prognosis. However, challenges in clinical treatment...

    Zhu Wang, Zhan Yang, ... **aolu Wang in International Urology and Nephrology
    Article Open access 30 May 2023
  6. Myeloid-derived Suppressor Cells Activate Liver Natural Killer Cells in a Murine Model in Uveal Melanoma

    Objective

    Elevated myeloid-derived suppressor cells (MDSCs) in many malignancies are associated with the increased risk for metastases and poor...

    Yuan-yuan Wang, Shuang-ying Li, ... Zhi-qiang Han in Current Medical Science
    Article 17 October 2022
  7. Natural killer cell immunotherapy in glioblastoma

    Glioblastoma (GBM) is one of the most difficult cancers to treat because GBM has the high therapeutic resistance. Recently, immunotherapies for GBM...

    Hamed Hosseinalizadeh, Mehryar Habibi Roudkenar, ... Tomoaki Sato in Discover Oncology
    Article Open access 28 October 2022
  8. Evolution of natural killer cell-targeted therapy for acute myeloid leukemia

    In hematologic oncology, acute myeloid leukemia (AML) presents a significant challenge due to its complex genetic landscape and resistance to...

    Yuta Kaito, Yoichi Imai in International Journal of Hematology
    Article 01 May 2024
  9. Reactivation of natural killer cells with monoclonal antibodies in the microenvironment of malignant neoplasms

    Natural killer cells are critical players in the antitumor immune response due to their ability to destroy target cells through cytotoxic activity...

    Luiz Ricardo Soldi, Victor Luigi Costa Silva, ... Marcelo José Barbosa Silva in Journal of Cancer Research and Clinical Oncology
    Article 12 January 2023
  10. Natural killer cells modified with a Gpc3 aptamer enhance adoptive immunotherapy for hepatocellular carcinoma

    Introduction

    Natural killer cells can attack cancer cells without prior sensitization, but their clinical benefit is limited owing to their poor...

    Youshi Zheng, Zisen Lai, ... Kecan Lin in Discover Oncology
    Article Open access 04 September 2023
  11. Increased ILT2+ natural killer T cells correlate with disease activity in systemic lupus erythematosus

    Objective

    Numerous immune cell types, such as B and T lymphocytes, natural killer cells (NK), and NKT cells, are related to the pathogenesis of...

    Ning Chen, Yijun Dai, ... Qing Yan in Clinical Rheumatology
    Article 11 September 2023
  12. Natural killer cells and acute myeloid leukemia: promises and challenges

    Acute myeloid leukemia (AML) is considered as one of the most malignant conditions of the bone marrow. Over the past few decades, despite substantial...

    Shayan Rahmani, Niloufar Yazdanpanah, Nima Rezaei in Cancer Immunology, Immunotherapy
    Article 31 May 2022
  13. A pilot study of cord blood-derived natural killer cells as maintenance therapy after autologous hematopoietic stem cell transplantation

    Natural killer (NK) cell based immunotherapy is an emerging strategy in hematologic malignancies because allogeneic NK cells can provide potent...

    Yuling Wu, Yue Wang, ... Ting Liu in Annals of Hematology
    Article 29 September 2023
  14. Peripheral neuropathy associated with chronic lymphoproliferative disorders of natural killer cells (CLPD-NK): a case report and literature review

    Background

    Chronic lymphoproliferative disorders of natural killer cells (CLPD-NK) is a rare lymphoproliferative disease. Peripheral neuropathy is an...

    Hong An, Jiaxiang Guo, ... Ming Lu in BMC Neurology
    Article Open access 01 September 2023
  15. Dissecting the inflammatory tumor microenvironment of esophageal adenocarcinoma: mast cells and natural killer cells are favorable prognostic factors and associated with less extensive disease

    Purpose

    Esophageal adenocarcinoma (EAC) remains a challenging and lethal cancer entity. A promising target for new therapeutic approaches, as...

    Alyne CondurĂº dos Santos Cunha, Adrian Georg Simon, ... Alexander Quaas in Journal of Cancer Research and Clinical Oncology
    Article Open access 24 February 2023
  16. Metabolic hallmarks of natural killer cells in the tumor microenvironment and implications in cancer immunotherapy

    Natural killer (NK) cells belong to the early responder group against cancerous cells and viral infection. Emerging evidence reveals that distinct...

    Yuqing Yang, Lin Chen, ... Shengtao Zhou in Oncogene
    Article 06 December 2022
  17. Immune Evasion of Hepatoma Cancer Stem-Like Cells from Natural Killer Cells

    Background

    Poor prognosis in liver cancer is due to its high frequency of intrahepatic metastasis. Cancer stem-like cells (CSLCs), which possess the...

    Yuta Kimura, Ryouichi Tsunedomi, ... Hiroaki Nagano in Annals of Surgical Oncology
    Article 25 July 2022
  18. Decreased natural killer T-like cells correlated to disease activity in systemic lupus erythematosus

    Objectives

    To evaluate the absolute numbers and frequencies of natural killer T-like (NKT-like) cells in systemic lupus erythematosus (SLE) and to...

    Sumei Tang, Yushu Wang, ... Yingni Li in Clinical Rheumatology
    Article 11 January 2023
  19. Immunohistochemical expression of CD155 in invasive female breast carcinoma and its correlation with tumor infiltrating natural killer cells

    Background

    CD155 is an immune checkpoint protein that interacts with ligands on natural killer cells to regulate the tumor associated immunity. CD155...

    Passant Essam Eldin Shibel, Eman Ahmed Abd Elmaogod in Beni-Suef University Journal of Basic and Applied Sciences
    Article Open access 13 March 2023
  20. Immune profiling of patients with extranodal natural killer/T cell lymphoma treated with daratumumab

    Natural killer/T cell lymphoma (NKTCL) is a highly aggressive, heterogeneous non-Hodgkin lymphoma resulting from malignant proliferation of cytotoxic...

    Min Qing, Tianyuan Zhou, ... Raluca I. Verona in Annals of Hematology
    Article Open access 18 January 2024
Did you find what you were looking for? Share feedback.